कृपया अन्य खोज का प्रयास करें
Molecure S.A., a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for the treatment of neoplastic and inflammatory diseases in Poland. The company is involved in the development of OATD-01, a chitotriosidase/AMCASE inhibitor that has completed phase I clinical trial for the treatment of sarcoidosis, as well as in preclinical stage to treat idiopathic pulmonary fibrosis and NASH. It also develops OATD-02, an arginase 1 and arginase 2, which is in Phase I clinical trial for the treatment of cancer; USP7, USP21, and YKL-40 for the treatment of cancer; and Deubiquitinase program. The company was formerly known as OncoArendi Therapeutics S.A. and changed its name to Molecure S.A. in March 2022. Molecure S.A. was founded in 2012 and is headquartered in Warsaw, Poland.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Piotr Zólkiewicz | - | 2021 | Independent Chairman of Supervisory Board |
Tomasz Piec | 52 | 2020 | Vice Chairman of the Supervisory Board |
Reynold A. Panettieri | - | - | Member of Scientific Advisory Board |
Bruce Conway | - | - | Member of Scientific Advisory Board |
Rafal Krenke | - | - | Member of Scientific Advisory Board |
Jakub Golab | - | - | Member of Scientific Advisory Board |
Douglas Hay | - | - | Member of Scientific Advisory Board |
Mariusz Ryszard Gromek | - | - | Member of Supervisory Board |
Nancy Van Osselaer | - | 2021 | Member of the Supervisory Board & Member of Scientific Advisory Board |
Bart N. Lambrecht | - | - | Member of Scientific Advisory Board |
Paul Van Der Horst | - | 2022 | Member of Supervisory Board |
Rafal M. Kaminski | - | 2020 | Member of the Supervisory Board |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है